New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.

Cancers(2023)

Cited 0|Views49
No score
Abstract
We highlighted the new insights associated with the use of currently available biomarkers as a standard of care for the management of CTRCD and identified potentially novel clinical biomarkers that could be further investigated as promising predictors of CTRCD.
More
Translated text
Key words
chemotherapy-induced cardiotoxicity, cancer therapy-induced cardiac dysfunction, clinical biomarkers, breast cancer, LVEF, BNP, troponins
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined